A planned April 25 showdown in Paris between Lawrence Okolie and French Olympic gold medalist Tony Yoka has been scrapped after Okolie was pulled into a major anti-doping controversy.
A high-profile April 25 boxing card in Paris has lost its main event after Lawrence Okolie was flagged for a failed drug test, knocking him out of a scheduled bout with Tony Yoka. The former two-division world champion was found to have GHRP-2 in his system, according to an official confirmation from Queensberry Promotions following VADA testing.
GHRP-2 is a synthetic peptide banned under anti-doping rules because it can stimulate growth hormone production, aid muscle development, and accelerate fat loss. For a heavyweight-level fight with major relevance to both fighters’ careers, the result immediately shifts the focus from competition to discipline and damage control.
For Okolie, the stakes now go far beyond one canceled night in Paris. If anti-doping authorities determine he knowingly used a prohibited substance, he could face a suspension of up to four years. Even if he successfully argues the substance entered his body unintentionally — through a contaminated supplement or treatment tied to injury recovery — he could still be sidelined for two years.
That matters in a big way for the division. Okolie had been trying to rebuild momentum and reestablish himself as a serious player in the heavyweight picture after moving up in weight. Yoka, meanwhile, was looking for a statement win on home soil that could have revived his path toward relevance in Europe and beyond. Instead, the fight card loses its headline attraction, and both careers are pushed into uncertainty.
American boxing fans may not have viewed Okolie-Yoka as a major U.S. draw, but the matchup had real intrigue as a crossroads fight between two once-hyped names trying to reclaim traction. Okolie has said he believes the investigation will clear him and pointed to possible links with treatment for a biceps injury.
Now the next development will come outside the ring, as Okolie’s case moves through the anti-doping process and the sport waits to see whether this is a temporary setback or a career-altering suspension.
